Physician

Nehal Kireet Bhatt, M.D.

According to 2025 Medicare claims, Nehal Bhatt, M.D. (NPI: 1255406377) practices pulmonary disease in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is ATHENS PULMONARY AND ALLERGY, P.C. (NPI: 1649337510; TIN: 581443753) and primary practice location at 30607-1400.

Bhatt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,089 traditional Medicare patients, billed 4,274 HCPCS/CPT codes, and received $235,039 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,338 prescription claims across 334 beneficiaries totaling $1,776,263 in drug costs, led by Tyvaso Dpi (Treprostinil). DME data shows 2,884 claims. Open Payments data shows 77 records totaling $85,087. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,651,058 and ending at $1,776,263. For DME billing, reported payments rose steadily, from $205,571 to $208,880.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$118K$235K2015 Medicare payment: $204,088 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $185,880 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $198,541 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $170,783 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $179,083 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $170,535 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $155,969 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $149,779 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $157,688 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $235,039 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0512,882$204,088
20169672,568$185,880
20179842,791$198,541
20188532,541$170,783
20198592,604$179,083
20208342,163$170,535
20218862,284$155,969
20227632,340$149,779
20238312,565$157,688
20241,0894,274$235,039

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.3M2015 Drug cost: $1,651,058 (USD; Tot_Drug_Cst)2016 Drug cost: $2,080,616 (USD; Tot_Drug_Cst)2017 Drug cost: $2,316,500 (USD; Tot_Drug_Cst)2018 Drug cost: $1,996,144 (USD; Tot_Drug_Cst)2019 Drug cost: $2,209,408 (USD; Tot_Drug_Cst)2020 Drug cost: $2,275,483 (USD; Tot_Drug_Cst)2021 Drug cost: $2,050,615 (USD; Tot_Drug_Cst)2022 Drug cost: $1,287,745 (USD; Tot_Drug_Cst)2023 Drug cost: $1,755,138 (USD; Tot_Drug_Cst)2024 Drug cost: $1,776,263 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153142,441$1,651,058
20163332,653$2,080,616
20173272,832$2,316,500
20183072,526$1,996,144
20193342,741$2,209,408
20203512,726$2,275,483
20212982,158$2,050,615
20222381,616$1,287,745
20232801,815$1,755,138
20243342,338$1,776,263

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$127K$253K2015 Medicare payment: $253,487 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $205,942 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $188,021 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $164,553 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $170,494 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $185,992 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $187,791 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $204,778 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $197,580 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $199,728 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20158792,823$253,487
20168212,877$205,942
20177982,621$188,021
20188882,485$164,553
20199372,753$170,494
20201,0192,671$185,992
20211,1203,017$187,791
20221,1262,788$204,778
20231,0432,845$197,580
20241,1322,884$199,728

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more318456$94
94729Test to examine how well the lungs exchange gases207221$40
94010Test to measure expiratory airflow and volume201221$19
71046X-ray of chest, 2 views218251$16
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's274352$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tyvaso DpiTreprostinil22616$517,319
Trelegy ElliptaFluticasone/Umeclidin/Vilanter2259,840$206,538
GlassiaAlpha-1-Proteinase Inhibitor13364$148,529
XolairOmalizumab12336$100,025
Prolastin CAlpha-1-Proteinase Inhibitor11308$83,972

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R56$56,716
A7031Face mask interface, replacement for full face mask, eachN75177$19,589
A7032Cushion for use on nasal mask interface, replacement only, eachN58141$18,517
A7030Full face mask used with positive airway pressure device, eachN79185$18,074
A7034Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strapN99235$15,052

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.77$85,087GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nehal Kireet Bhatt, M.D.?

Tedicare shows public-source Medicare data for Nehal Kireet Bhatt, M.D. (NPI 1255406377), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nehal Kireet Bhatt, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nehal Kireet Bhatt, M.D.?

Nehal Kireet Bhatt, M.D. is linked to ATHENS PULMONARY AND ALLERGY, P.C. (billing NPI 1649337510) in the available physician profile data.

Does Nehal Kireet Bhatt, M.D. have Open Payments data?

Nehal Kireet Bhatt, M.D. has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.